Finsterer, J., & Zarrouk-Mahjoub, S. (2017). Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed()()()(). Mol Genet Metab Rep.
Chicago Style CitationFinsterer, Josef, i Sinda Zarrouk-Mahjoub. "Costs for Mitochondrial Medicine Will Remain High As Long As Mitochondrial Disorders Are Misdiagnosed()()()()." Mol Genet Metab Rep 2017.
Cita MLAFinsterer, Josef, i Sinda Zarrouk-Mahjoub. "Costs for Mitochondrial Medicine Will Remain High As Long As Mitochondrial Disorders Are Misdiagnosed()()()()." Mol Genet Metab Rep 2017.
Atenció: Aquestes cites poden no estar 100% correctes.